The Center for Global Health Innovation Selects Former American Cancer Society CEO, Gary M. Reedy, as Chairman of their Board
02 Feb 2023
Executive Change
ATLANTA--(BUSINESS WIRE)--The Center for Global Health Innovation (CGHI/The Center) announced today that Gary M. Reedy will be their new chairman. Mr. Reedy was CEO of the American Cancer Society (ACS) and the American Cancer Society Cancer Action Network (ACS CAN) from 2015 to 2021, following 15 years of volunteer leadership for the organization, including chairing the Boards of Directors for the ACS and its advocacy affiliate, the ACS CAN.
'Leading the Center for Global Health Innovation through the COVID-19 Pandemic has been one of the most rewarding challenges of my career'
As the most senior leader of the only global nonprofit organization attacking cancer from every angle, Reedy ignited the movement to save lives, celebrate lives, and lead the fight for a world without cancer. Reedy transformed the organization into one that is impact-focused, volunteer-driven, and committed to ensuring breakthroughs in cancer prevention, screening, and treatments. His leadership emphasized disciplined focus on maximizing the Society’s support of progress against cancer, optimizing volunteer and customer experiences, expanding stewardship and engagement, leading innovation, and advancing health equity.
Previously, Reedy served as worldwide vice president, government affairs and policy at Johnson & Johnson, president of Ortho Biotech, and in senior leadership roles at SmithKline Beecham and Centocor.
“I have dedicated my life to improving the health of people around the globe. I brought that vision to the American Cancer Society as their chief executive officer, and I will use the knowledge and experience I gained there to further CGHI’s mission of advancing global health equity through collaboration and health innovation,” said Reedy.
Mr. Reedy succeeds Russell M. Medford, MD, PHD as board chair. “Leading the Center for Global Health Innovation through the COVID-19 Pandemic has been one of the most rewarding challenges of my career,” said Dr. Medford, Chairman and CEO, Covanos, Inc. “During my time as board chair, we have shown the world that Georgia has the right combination of science, technology, commercial innovation, health equity, research and international reach to be our country’s epicenter for global health. I am supremely confident that Gary is the right person to steer CGHI toward our vision of global health equity, and I wish him well.”
ABOUT The Center for Global Health Innovation (CGHI) is a 501(c)(3) organization that was launched in January 2020 to bring together diverse Global Health, Health Technology and Life Sciences entities to collaborate, innovate and activate solutions to enhance health outcomes around the world. Follow CGHI on Twitter (@Center4Global) and on Facebook and LinkedIn.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.